Ausgabe 1/2014
Inhalt (7 Artikel)
Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications
Eugenia Yiannakopoulou
Clinical application of circulating tumor cells in breast cancer
Leonie H. A. Broersen, Gabi W. van Pelt, Rob A. E. M. Tollenaar, Wilma E. Mesker
Thymidylate synthase expression and p21WAF1/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy
Violetta Sulzyc-Bielicka, Pawel Domagala, Dariusz Bielicki, Krzysztof Safranow, Wenancjusz Domagala
Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management
Ilda Patrícia Ribeiro, Francisco Marques, Francisco Caramelo, João Pereira, Miguel Patrício, Hugo Prazeres, José Ferrão, Maria José Julião, Miguel Castelo-Branco, Joana Barbosa de Melo, Isabel Poiares Baptista, Isabel Marques Carreira
High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection
Mariette Labots, Tineke E. Buffart, Josien C. Haan, Nicole C. T. van Grieken, Marianne Tijssen, Cornelis J. H. van de Velde, Heike I. Grabsch, Bauke Ylstra, Beatriz Carvalho, Remond J. A. Fijneman, Henk M. W. Verheul, Gerrit A. Meijer
A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells
Yong Wu, Min Tang, Yuan Wu, Xinxian Weng, Lifang Yang, Wen Xu, Wie Yi, Jinghe Gao, Ann M. Bode, Zigang Dong, Ya Cao
Loss of NF2/Merlin expression in advanced sporadic colorectal cancer
Tamara Čačev, Gorana Aralica, Božo Lončar, Sanja Kapitanović